Literature DB >> 2852416

Marek's disease virus serotype-1 antigens A and B and their unglycosylated precursors detected by Western blot analysis of infected cells.

I Davidson1, M Malkinson, Y Becker.   

Abstract

The antigenic profile of cell cultures infected with Marek's disease virus (MDV) was determined by the immunoblotting method using convalescent immune serum obtained from chickens that survived infection with MDV strain GA5. The MDV antigen profile in infected cell lysates could be accurately determined since this method has advantages over the immunoprecipitation method used in other studies. We studied six very virulent MDV isolates and the prototype of serotype 1 MDV, the GA5 strain. Immunoblots of NaDodSO4-polyacrylamide gel electrophoresis (PAGE) performed under reducing conditions revealed a main viral antigen (B) of 120-130 kD, which was present in all cell lysates infected with MDV isolates. Analysis of infected cell proteins by NaDodSO4-PAGE performed under nonreducing conditions, revealed a 205 kD major MDV antigen, which, under reducing conditions, was identical to the 130 kD major antigen. The unglycosylated precursors of the major MDV antigens were elucidated. Two polypeptides of 43 and 45 kD were found to be the unglycosylated precursors of MDV antigen A (the glycosylated form of which appears in 4 distinct bands). The unglycosylated precursors of the MDV major antigen B were found to be three polypeptides of 80, 110, and 125 kD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852416     DOI: 10.1007/bf00569733

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  26 in total

1.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

2.  Immune responses to isolated human cytomegalovirus envelope proteins.

Authors:  E Gönczöl; F Hudecz; J Ianacone; B Dietzschold; S Starr; S A Plotkin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus.

Authors:  K Hirai; K Nakajima; K Ikuta; R Kirisawa; Y Kawakami; T Mikami; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Monoclonal antibodies specific to and cross-reactive with Marek's disease virus and herpesvirus of turkeys.

Authors:  K Ikuta; H Honma; K Maotani; S Ueda; S Kato; K Hirai
Journal:  Biken J       Date:  1982-12

7.  Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization.

Authors:  K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

9.  Map location of the gene for a 130,000-dalton glycoprotein of bovine herpesvirus 1.

Authors:  W C Lawrence; R C D'urso; C A Kundel; J C Whitbeck; L J Bello
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Molecular characterization of Marek's disease herpesvirus B antigen.

Authors:  R J Isfort; I Sithole; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

View more
  5 in total

1.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: evidence for splicing of mRNA from a new viral glycoprotein gene.

Authors:  Y Becker; Y Asher; E Tabor; I Davidson; M Malkinson
Journal:  Virus Genes       Date:  1994-01       Impact factor: 2.332

3.  Antigen B of the vaccine strains of Marek's disease virus and herpesvirus of turkeys presents heat-labile group and serotype specific epitopes.

Authors:  M Malkinson; I Davidson; Y Becker
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen.

Authors:  X Chen; L F Velicer
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.